Zhao et al. found that NPS treatment reversed cognitive deficits in a mouse model of AD by upregulating the levels of postsynaptic density protein 95 (PSD95) and synapsin 1 in hippocampal CA1 neurons [25]. This evidence concerns the gene DLG4 and Alzheimer disease.